Alignment Healthcare (ALHC) Stock Forecast, Price Target & Predictions
ALHC Stock Forecast
Alignment Healthcare stock forecast is as follows: an average price target of $9.50 (represents a 0.00% downside from ALHC’s last price of $9.50) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
ALHC Price Target
The average price target for Alignment Healthcare (ALHC) is $9.50 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $12.00 to $7.00. This represents a potential 0.00% downside from ALHC's last price of $9.50.
ALHC Analyst Ratings
According to 12 Wall Street analysts, Alignment Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for ALHC stock is 1 'Strong Buy' (8.33%), 7 'Buy' (58.33%), 3 'Hold' (25.00%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).
Alignment Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 14, 2024 | Michael Ha | Robert W. Baird | $11.00 | $8.49 | 29.56% | 15.79% |
| Aug 05, 2024 | Andrew Mok | Barclays | $7.00 | $8.94 | -21.70% | -26.32% |
| Jul 26, 2024 | Craig Jones | Stifel Nicolaus | $12.00 | $9.36 | 28.21% | 26.32% |
| May 08, 2024 | Jessica Tassan | Piper Sandler | $8.00 | $6.78 | 17.99% | -15.79% |
| Oct 16, 2023 | John Ransom | Raymond James | $10.00 | $6.62 | 51.06% | 5.26% |
| Oct 12, 2023 | Scott Fidel | Stephens | $9.00 | $6.29 | 43.20% | -5.26% |
The latest Alignment Healthcare stock forecast, released on Aug 14, 2024 by Michael Ha from Robert W. Baird, set a price target of $11.00, which represents a 29.56% increase from the stock price at the time of the forecast ($8.49), and a 15.79% increase from ALHC last price ($9.50).
Alignment Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 6 |
| Avg Price Target | $11.00 | $10.00 | $9.50 |
| Last Closing Price | $9.50 | $9.50 | $9.50 |
| Upside/Downside | 15.79% | 5.26% | - |
In the current month, the average price target of Alignment Healthcare stock is $11.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 15.79% increase as opposed to Alignment Healthcare's last price of $9.50. This month's average price target is up 10.00% compared to last quarter, and up 15.79% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 06, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Aug 05, 2024 | Barclays | Underweight | Underweight | Hold |
| May 03, 2024 | Stephens | Equal-Weight | Equal-Weight | Hold |
| Oct 16, 2023 | Raymond James | Outperform | Strong Buy | Upgrade |
| Oct 12, 2023 | Needham | - | Hold | Initialise |
| Oct 12, 2023 | UBS | - | Buy | Initialise |
| Oct 12, 2023 | BMO Capital | - | Outperform | Initialise |
| Oct 12, 2023 | Stephens | - | Equal-Weight | Initialise |
| Oct 12, 2023 | Seaport Global | - | Buy | Initialise |
Alignment Healthcare's last stock rating was published by Piper Sandler on Aug 06, 2024. The company gave ALHC a "Overweight" rating, the same as its previous rate.
Alignment Healthcare Financial Forecast
Alignment Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $465.39M | $456.71M | $462.38M | $439.15M | $361.81M | $360.35M | - | $345.53M | $298.27M | $293.47M | $308.95M | $267.08M |
| Avg Forecast | $962.06M | $967.01M | $990.69M | $965.69M | $808.63M | $810.12M | $837.77M | $803.23M | $659.51M | $661.30M | $637.66M | $599.75M | $444.56M | $443.45M | $438.97M | $431.34M | $341.10M | $333.40M | $336.97M | $332.48M | $269.57M | $275.48M | $267.35M | $250.91M |
| High Forecast | $968.31M | $973.30M | $997.14M | $971.97M | $813.88M | $815.39M | $843.22M | $808.45M | $663.80M | $665.35M | $641.81M | $603.65M | $462.23M | $446.33M | $441.83M | $434.15M | $343.32M | $335.57M | $336.97M | $340.46M | $276.05M | $282.10M | $273.77M | $256.93M |
| Low Forecast | $957.87M | $962.80M | $986.38M | $961.48M | $805.11M | $806.59M | $834.12M | $799.73M | $656.64M | $659.26M | $634.89M | $597.14M | $435.24M | $441.52M | $437.06M | $429.46M | $339.62M | $331.95M | $336.97M | $322.08M | $261.14M | $266.86M | $258.99M | $243.06M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 2 | 3 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.03% | 1.05% | 1.02% | 1.06% | 1.08% | - | 1.04% | 1.11% | 1.07% | 1.16% | 1.06% |
Alignment Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $599.75M, with a low forecast of $597.14M, and a high forecast of $603.65M. ALHC's average Quarter revenue forecast represents a 28.87% increase compared to the company's last Quarter revenue of $465.39M (Dec 23).
Alignment Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 2 | 3 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-35.95M | $-24.11M | $-18.02M | $-27.37M | $-47.34M | $-28.77M | - | $-32.42M | $-43.25M | $-37.27M | $-36.47M | $-48.84M |
| Avg Forecast | $-54.18M | $-54.46M | $-55.79M | $-54.38M | $-45.54M | $-45.62M | $-47.18M | $-45.23M | $-37.14M | $-37.24M | $-35.91M | $-33.77M | $-25.03M | $-24.97M | $-24.72M | $-24.29M | $-19.21M | $-21.22M | $-18.98M | $-35.02M | $-15.18M | $-19.29M | $-18.91M | $-42.13M |
| High Forecast | $-53.94M | $-54.22M | $-55.55M | $-54.14M | $-45.34M | $-45.42M | $-46.97M | $-45.04M | $-36.98M | $-37.13M | $-35.75M | $-33.63M | $-24.51M | $-24.86M | $-24.61M | $-24.18M | $-19.12M | $-16.98M | $-18.98M | $-28.01M | $-14.71M | $-15.43M | $-15.13M | $-33.71M |
| Low Forecast | $-54.53M | $-54.81M | $-56.15M | $-54.73M | $-45.83M | $-45.92M | $-47.48M | $-45.53M | $-37.38M | $-37.47M | $-36.14M | $-33.99M | $-26.03M | $-25.13M | $-24.88M | $-24.45M | $-19.33M | $-25.47M | $-18.98M | $-42.02M | $-15.55M | $-23.15M | $-22.69M | $-50.56M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.44% | 0.97% | 0.73% | 1.13% | 2.46% | 1.36% | - | 0.93% | 2.85% | 1.93% | 1.93% | 1.16% |
undefined analysts predict ALHC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alignment Healthcare's previous annual EBITDA (undefined) of $NaN.
Alignment Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 2 | 3 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-47.21M | $-35.05M | $-28.48M | $-37.37M | $-56.99M | $-40.25M | - | $-45.16M | $-52.29M | $-45.82M | $-44.76M | $-56.87M |
| Avg Forecast | $-27.73M | $-8.07M | $-7.77M | $-35.83M | $-29.56M | $-18.54M | $-15.63M | $-39.65M | $-33.57M | $-27.08M | $-27.25M | $-43.42M | $-43.25M | $-35.02M | $-34.92M | $-48.73M | $-56.69M | $-26.09M | $-48.63M | $-44.08M | $-52.13M | $-23.72M | $-23.21M | $-49.07M |
| High Forecast | $-27.57M | $-8.02M | $-7.73M | $-35.63M | $-29.40M | $-18.43M | $-15.54M | $-39.43M | $-33.38M | $-21.27M | $-27.09M | $-43.17M | $-37.35M | $-34.82M | $-34.73M | $-48.45M | $-56.37M | $-20.87M | $-48.63M | $-35.27M | $-50.00M | $-18.97M | $-18.57M | $-39.25M |
| Low Forecast | $-27.97M | $-8.14M | $-7.84M | $-36.13M | $-29.81M | $-18.69M | $-15.76M | $-39.99M | $-33.86M | $-29.01M | $-27.48M | $-43.78M | $-49.15M | $-35.31M | $-35.22M | $-49.14M | $-57.17M | $-31.31M | $-48.63M | $-52.90M | $-53.75M | $-28.46M | $-27.85M | $-58.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.00% | 0.82% | 0.77% | 1.01% | 1.54% | - | 1.02% | 1.00% | 1.93% | 1.93% | 1.16% |
Alignment Healthcare's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALHC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Alignment Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 2 | 3 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $83.74M | $83.09M | $70.20M | $70.41M | $83.23M | $76.45M | - | $74.29M | $78.08M | $76.85M | $71.15M | $64.91M |
| Avg Forecast | $179.41M | $180.34M | $184.76M | $180.09M | $150.80M | $151.08M | $156.24M | $149.79M | $122.99M | $123.33M | $118.92M | $111.85M | $82.91M | $82.70M | $81.86M | $80.44M | $63.61M | $43.76M | $62.84M | $80.24M | $50.27M | $39.78M | $36.89M | $56.00M |
| High Forecast | $180.58M | $181.51M | $185.96M | $181.26M | $151.78M | $152.06M | $157.25M | $150.77M | $123.79M | $124.08M | $119.69M | $112.58M | $86.20M | $83.24M | $82.40M | $80.96M | $64.03M | $52.51M | $62.84M | $96.28M | $51.48M | $47.73M | $44.27M | $67.20M |
| Low Forecast | $178.63M | $179.55M | $183.95M | $179.31M | $150.14M | $150.42M | $155.56M | $149.14M | $122.46M | $122.95M | $118.40M | $111.36M | $81.17M | $82.34M | $81.51M | $80.09M | $63.34M | $35.01M | $62.84M | $64.19M | $48.70M | $31.82M | $29.51M | $44.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.00% | 0.86% | 0.88% | 1.31% | 1.75% | - | 0.93% | 1.55% | 1.93% | 1.93% | 1.16% |
Alignment Healthcare's average Quarter SG&A projection for Mar 24 is $111.85M, based on 4 Wall Street analysts, with a range of $111.36M to $112.58M. The forecast indicates a 33.57% rise compared to ALHC last annual SG&A of $83.74M (Dec 23).
Alignment Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 2 | 3 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.25 | $-0.19 | $-0.15 | $-0.20 | $-0.31 | $-0.22 | - | $-0.25 | $-0.29 | $-0.26 | $-0.25 | $-0.37 |
| Avg Forecast | $-0.15 | $-0.04 | $-0.04 | $-0.19 | $-0.15 | $-0.10 | $-0.08 | $-0.21 | $-0.18 | $-0.14 | $-0.14 | $-0.23 | $-0.23 | $-0.18 | $-0.18 | $-0.26 | $-0.30 | $-0.24 | $-0.26 | $-0.23 | $-0.28 | $-0.16 | $-0.11 | $-0.19 |
| High Forecast | $-0.14 | $-0.04 | $-0.04 | $-0.19 | $-0.15 | $-0.10 | $-0.08 | $-0.21 | $-0.17 | $-0.11 | $-0.14 | $-0.23 | $-0.20 | $-0.18 | $-0.18 | $-0.25 | $-0.30 | $-0.24 | $-0.26 | $-0.22 | $-0.27 | $-0.16 | $-0.10 | $-0.18 |
| Low Forecast | $-0.15 | $-0.04 | $-0.04 | $-0.19 | $-0.16 | $-0.10 | $-0.08 | $-0.21 | $-0.18 | $-0.15 | $-0.14 | $-0.23 | $-0.26 | $-0.18 | $-0.18 | $-0.26 | $-0.30 | $-0.25 | $-0.26 | $-0.24 | $-0.29 | $-0.17 | $-0.11 | $-0.19 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 1.04% | 0.82% | 0.78% | 1.04% | 0.90% | - | 1.09% | 1.05% | 1.59% | 2.38% | 1.97% |
According to undefined Wall Street analysts, Alignment Healthcare's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALHC previous annual EPS of $NaN (undefined).
Alignment Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BHG | NeueHealth | $16.35 | $7.68K | 46872.48% | Hold |
| CVS | CVS Health | $57.75 | $103.77 | 79.69% | Hold |
| HUM | Humana | $357.86 | $500.84 | 39.95% | Hold |
| CNC | Centene | $70.83 | $93.33 | 31.77% | Buy |
| OSCR | Oscar Health | $16.99 | $20.20 | 18.89% | Buy |
| MOH | Molina Healthcare | $327.48 | $358.63 | 9.51% | Hold |
| ELV | Elevance Health | $541.91 | $556.91 | 2.77% | Buy |
| ALHC | Alignment Healthcare | $9.50 | $9.50 | - | Buy |
| UNH | UnitedHealth Group | $596.88 | $569.20 | -4.64% | Buy |
| CI | Cigna | $353.49 | $318.74 | -9.83% | Buy |
| CLOV | Clover Health Investments | $2.51 | $2.15 | -14.34% | Hold |
ALHC Forecast FAQ
Is Alignment Healthcare a good buy?
Yes, according to 12 Wall Street analysts, Alignment Healthcare (ALHC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 7 'Buy' recommendations, accounting for 66.67% of ALHC's total ratings.
What is ALHC's price target?
Alignment Healthcare (ALHC) average price target is $9.5 with a range of $7 to $12, implying a 0% from its last price of $9.5. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Alignment Healthcare stock go up soon?
According to Wall Street analysts' prediction for ALHC stock, the company can go down by 0% (from the last price of $9.5 to the average price target of $9.5), up by 26.32% based on the highest stock price target, and down by -26.32% based on the lowest stock price target.
Can Alignment Healthcare stock reach $14?
ALHC's average twelve months analyst stock price target of $9.5 does not support the claim that Alignment Healthcare can reach $14 in the near future.
What is Alignment Healthcare's current price target trend?
1 Wall Street analyst forecast a $11 price target for Alignment Healthcare (ALHC) this month, up 15.79% from its last price of $9.5. Compared to the last 3 and 12 months, the average price target increased by 5.26% and increased by 0%, respectively.
What are Alignment Healthcare's analysts' financial forecasts?
Alignment Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.26B (high $3.28B, low $3.25B), average EBITDA is $-184M (high $-183M, low $-185M), average net income is $-103M (high $-103M, low $-104M), average SG&A $607.91M (high $611.87M, low $605.27M), and average EPS is $-0.542 (high $-0.539, low $-0.546). ALHC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.89B (high $3.91B, low $3.87B), average EBITDA is $-219M (high $-218M, low $-220M), average net income is $-79.403M (high $-78.955M, low $-80.076M), average SG&A $724.6M (high $729.31M, low $721.45M), and average EPS is $-0.416 (high $-0.414, low $-0.419).
Did the ALHC's actual financial results beat the analysts' financial forecasts?
Based on Alignment Healthcare's last annual report (Dec 2023), the company's revenue was $1.82B, beating the average analysts forecast of $1.76B by 3.71%. Apple's EBITDA was $-105M, beating the average prediction of $-99.017M by 6.44%. The company's net income was $-148M, missing the average estimation of $-162M by -8.59%. Apple's SG&A was $307.43M, missing the average forecast of $327.91M by -6.25%. Lastly, the company's EPS was $-0.79, missing the average prediction of $-0.848 by -6.87%. In terms of the last quarterly report (Dec 2023), Alignment Healthcare's revenue was $465.39M, beating the average analysts' forecast of $444.56M by 4.69%. The company's EBITDA was $-35.948M, beating the average prediction of $-25.035M by 43.59%. Alignment Healthcare's net income was $-47.209M, beating the average estimation of $-43.252M by 9.15%. The company's SG&A was $83.74M, beating the average forecast of $82.91M by 1.00%. Lastly, the company's EPS was $-0.25, beating the average prediction of $-0.227 by 10.34%